Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

Rescheduling Happened: What State-Licensed Medical Cannabis Operators Need to Know and Do Immediately

By Whitt Steineker on April 27, 2026
Email this postTweet this postLike this postShare this post on LinkedIn
Rescheduling Happened: What State-Licensed Medical Cannabis Operators Need to Know and Do Immediately

Table of Contents

  • Registration
  • Know Your Lane
  • Records, Reports, and Order Forms
  • Prescriptions
  • Labeling, Packaging, and Security
  • The DEA Crop Purchase Quirk
  • Watch Your State License
  • Tax
  • Conclusion

This is the first of 13 posts over the next 13 business days describing the impacts of marijuana’s rescheduling. An homage to Phish’s historic run at Madison Square Garden in the Summer of 2017, Budding Trends Baker’s Dozen will address how rescheduling affects various areas of the law and our daily lives. Enjoy the run.

Ok, campers, rise and shine — the federal government has finally, albeit partially, rescheduled medical marijuana. If you are a state-licensed medical cannabis operator, this is good news in a number of ways. You’re no longer subject to 280E (and perhaps that will apply retroactively) and it should be easier to access capital from banks and investors. You’re also far less likely to find yourself running afoul of the law in the day-to-day operation of your business.

But, and this is significant, these benefits are not self-executing. State-licensed medical cannabis operators must register with the DEA (ideally within the next 60 days) and follow certain specific requirements set out in the acting attorney general’s final order.

Here’s what you need to know and do:

Link to Registration Registration

Apply for DEA registration as a manufacturer, distributor, or dispenser. Submit proof of your state medical marijuana license along with the applicable DEA form(s). The good news: If you apply within 60 days of publication, you can keep operating under your state license while DEA processes your application, which DEA is directed to complete within six months. Your state license serves as conclusive evidence of state-law authorization, so DEA must grant registration unless doing so would be inconsistent with the public interest or relevant international treaties (most importantly, the Single Convention).

Link to Know Your Lane Know Your Lane

Your DEA registration is capped at what your state license allows. Manufacturers can cultivate, produce, process, package, label, and transfer to registered distributors or other manufacturers. Distributors can receive from manufacturers and transfer to dispensers or other distributors. Dispensers can dispense to individuals authorized by state law to possess marijuana for medical purposes. None of these registrations authorize non-medical purposes.

Link to Records, Reports, and Order Forms Records, Reports, and Order Forms

You only need to submit what the DEA administrator determines is necessary to satisfy federal statutory and treaty obligations — and state-required records are accepted to the maximum extent permissible. This is a deliberate burden-reduction measure for operators.

Link to Prescriptions Prescriptions

State-authorized certifications or similar documents (including electronic ones) are sufficient for dispensing, as long as they include the user’s name and address, are dated and signed on the day of issuance, and identify issuing practitioners with their state license number.

Link to Labeling, Packaging, and Security Labeling, Packaging, and Security

You can rely on state-law requirements for labeling, packaging, disposal, and physical security in lieu of otherwise-applicable federal requirements, as long as your label includes the statutory warning required by 21 U.S.C. § 825(c) (“The Secretary shall prescribe regulations under section 353(b) of this title which shall provide that the label of a drug listed in schedule II, III, or IV shall, when dispensed to or for a patient, contain a clear, concise warning that it is a crime to transfer the drug to any person other than the patient”).

Link to The DEA Crop Purchase Quirk The DEA Crop Purchase Quirk

Manufacturers have an unusual additional obligation tied to the Single Convention: You must establish a nominal price for your marijuana crops, after which DEA purchases them at that price and sells them back to you (or a related entity) at the same price plus an administrative fee. You must also store crops in a facility to which DEA maintains access until that transaction is complete, and your registration must specify the areas where cultivation is permitted.

Link to Watch Your State License Watch Your State License

If your state license is suspended, revoked, or expires, your DEA registration automatically suspends. Federal authorization tracks state authorization, so keeping your state license in good standing is essential.

Link to Tax Tax

Consult your tax counsel about Section 280E. The order notes that state licensees will no longer be subject to that deduction disallowance going forward, and the DEA even encourages Treasury to consider retroactive relief — but the order explicitly says it is not a determination of federal tax liability. Contact us so that we can put you in touch with our tax professionals to advise on appropriate tax mitigation strategies.

Link to Conclusion Conclusion

This is a big deal. The biggest deal in marijuana in the last 50 years, if not ever. But state-licensed medical cannabis operators need to be thoughtful and diligent about applying the new rules.

As always, we’ll stay on top of this as circumstances unfold. There will be much, much more as this new regime rolls out.

Thanks for stopping by.

Photo of Whitt Steineker Whitt Steineker

As co-chair of Bradley’s Cannabis Industry team, Whitt represents clients in a wide range of cannabis issues. In addition to providing a full suite of legal services to cannabis companies, Whitt and the Cannabis Industry team advise non-cannabis clients – from banks to…

As co-chair of Bradley’s Cannabis Industry team, Whitt represents clients in a wide range of cannabis issues. In addition to providing a full suite of legal services to cannabis companies, Whitt and the Cannabis Industry team advise non-cannabis clients – from banks to commercial real estate companies to insurance companies and high net worth individuals – on best practices for interacting with cannabis companies.

Whitt is one of the leading voices in the cannabis bar – recognized as a “Go-To Thought Leader” by the National Law Review. He has presented on cannabis issues at conferences around the country.  His work has been featured in the National Law Journal, Law360, and the Westlaw Journal. And he has been quoted in an array of legal and mainstream publications from Law360 and Super Lawyers to the Atlanta Journal-Constitution and the Associated Press.

Read more about Whitt SteinekerEmailWhitt's Linkedin Profile
Show more Show less
  • Posted in:
    Cannabis
  • Blog:
    Budding Trends
  • Organization:
    Bradley Arant Boult Cummings LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo